Higher Biological Age Linked to Increased Dementia Risk, New Study Finds

Higher Biological Age May Elevate Dementia Risk
A recent study published in Neurology reveals that individuals with a biological age higher than their chronological age are approximately 30% more likely to develop dementia. Biological age, influenced by overall health and lifestyle factors, can differ from an individual's actual age based on birth date.
Key insights from the research:
- The study analyzed data from over 280,000 participants in the UK Biobank, with an average age of 57, followed for about 14 years.
- Researchers calculated biological age using biomarkers such as lung function, blood pressure, cholesterol, and white blood cell count.
- Participants with the most advanced biological age showed a significantly higher risk of dementia.
- Brain scans indicated that higher biological age is associated with loss of gray matter, which is critical for cognitive functions and linked to Alzheimer’s disease.
Implications and preventive measures:
Experts emphasize the importance of lifestyle choices, such as healthy diet, regular exercise, managing blood pressure and cholesterol, and adequate sleep, in influencing biological age. Healthcare professionals advocate for preventive healthcare strategies to mitigate dementia risk.
Expert opinions:
- Dr. Yacong Bo highlights that while age is unchangeable, biological age can be influenced by lifestyle, potentially reducing dementia risk.
- Dr. Cheng-Han Chen underscores the multifactorial nature of dementia and the role of healthy habits.
- Dr. Rehan Aziz stresses the importance of regular health screenings and lifestyle modifications to decrease biological age.
This research supports the ongoing efforts to promote healthy aging and underscores the potential of lifestyle interventions in reducing dementia risk.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Collaborative Initiative Aims to Enhance Mental Health Diagnosis with Biological Testing
A global coalition is working to revolutionize mental health diagnosis by integrating biological tests such as MRI, blood analyses, and digital tools, aiming for more accurate and personalized psychiatric care in the coming decades.
Repurposing Diabetes Medication Shows Promise for Liver Disease Patients
A groundbreaking clinical trial reveals that dapagliflozin, a diabetes medication, may significantly improve outcomes for patients with metabolic-associated liver disease, opening new possibilities for treating liver inflammation and fibrosis.
Socio-Economic Disparities in Dementia Care in Quebec
A groundbreaking study uncovers significant socio-economic disparities in dementia care in Quebec, revealing unequal access and treatment outcomes despite universal healthcare. The research emphasizes the urgent need for equitable health policies.